Weight and Fertility: What the Evidence Actually Shows

The honest picture, with numbers

The evidence on weight and fertility is real. The way it is usually delivered is not. This article separates the two, because being handed a BMI target without support — or being told to come back when you have lost two stone — is neither what the guidelines say nor what the trials found.

ASRM's committee opinion on obesity and reproduction opens with the sentence most often left out: although obesity increases the risk of infertility, most women and men with obesity are fertile. It goes on to describe the mechanism accurately — obesity is associated with ovulatory dysfunction, reduced ovarian responsiveness to agents that induce ovulation, altered oocyte and endometrial function, and lower birth rates after IVF — and it puts pregnancy loss at an odds ratio of 1.31.

NICE guideline NG257 states that a BMI of 30 or over is associated with taking longer to conceive, and that if you are not ovulating, losing weight is likely to increase your chance of conception. It also states that men with a BMI of 30 or over have an increased risk of reduced fertility, which is a part of the same guidance that is quietly dropped in most conversations.

Then the part that changes what you should do. Two randomised trials tested whether losing weight before treatment improves the outcome. The Dutch LIFEstyle trial randomised 577 women with a BMI of 29 or above to a six-month lifestyle programme or usual care; healthy live births were 27% in the intervention group and 35% in the control group. The American FIT-PLESE trial randomised 379 women with a BMI of 30 or above to intensive weight loss or exercise without targeted weight loss; the intensive group lost an average of 6.6% of body weight against 0.3% in the comparison group, and healthy live births were 12.2% versus 15.2% (rate ratio 0.81, 95% CI 0.48 to 1.34).

Neither trial showed a fertility benefit from pre-treatment weight loss. ASRM states the conclusion directly: in ovulatory women with obesity, prepregnancy weight loss interventions have not been shown to improve the outcome of live birth after either non-ART therapy or IVF.

What actually affects it

Where weight loss does help

The evidence splits on one question: are you ovulating? ASRM states that in anovulatory women with obesity, weight loss interventions improve the chance of unassisted conception, and improve the ovulation rate in response to ovulation induction. NG257 makes the same distinction — its recommendation about losing weight is explicitly conditional on not ovulating. If your cycles are regular and progesterone testing confirms ovulation, the mechanism weight loss is supposed to fix is not the one that is broken.

What support actually works

NG257 states that participating in a group programme involving exercise and dietary advice leads to more pregnancies than weight-loss advice alone. That sentence is an acknowledgement, written into national guidance, that telling someone to lose weight without support does not work. If weight is being raised with you, a referral to a structured programme is the evidence-based response; a target and a follow-up appointment in six months is not.

Being underweight

The guidance runs in both directions and the low-weight half is rarely mentioned. NG257 advises that people with a BMI under 18.5 who have irregular or absent periods are likely to improve their chance of conception by increasing body weight. For hypogonadotropic hypogonadism with anovulatory infertility, NG257 recommends increasing body weight towards a healthy weight if BMI is under 18.5, and moderating exercise levels if these are high.

Benefits that are real but are not fertility

ASRM notes that weight loss before IVF may lead to a lower procedural complication rate, and that weight loss before pregnancy may decrease the risk of some pregnancy complications. FIT-PLESE found genuine cardiometabolic improvement in its intensive group. These are worthwhile outcomes. They are not the same claim as improving your chance of a live birth, and it is reasonable to ask a clinician which of the two they are offering.

Male partners

ASRM records that men with obesity were more likely to experience infertility, that live birth rate per ART cycle was reduced, and that there was a 10% absolute increase in risk of pregnancy non-viability. Fertility is not a single-body problem and weight conversations that address only one partner are incomplete.

Being refused treatment because of a number

This is where the evidence and the practice diverge most sharply, and it is worth having the exact wording. ASRM's committee opinion states that on the basis of available evidence there is no medical or ethical directive for adopting a society-wide BMI threshold for offering infertility treatment, and that there is considerable evidence arguing against such a policy. It adds that obesity should not be the sole criterion for denying a patient or couple access to infertility treatment.

Funders and clinics apply BMI thresholds anyway, for reasons that mix anaesthetic safety, obstetric risk and cost. Those are arguments that can be made honestly. The dishonest version is presenting a commissioning rule as though it were a clinical finding about your body. If you are being asked to reach a BMI target before treatment, ask which of the two it is, and ask for it in writing. If it is a funding rule, the relevant question is what the threshold is and what support is funded to help you meet it.

What to do next

1. Establish whether you ovulate first. NICE recommends a mid-luteal serum progesterone test — day 21 of a 28-day cycle — even in people with regular cycles. That single result determines which half of the evidence applies to you.
2. Ask for a structured programme, not a target. NG257's recommendation is for a group programme combining exercise and dietary advice.
3. Ask for the rest of the investigation to proceed in parallel. Tubal assessment and semen analysis do not depend on your weight and should not be held behind it.
4. Ask what any BMI threshold is for. Anaesthetic safety at egg collection, obstetric risk and funding eligibility are three different arguments with three different answers.
5. If your BMI is under 18.5 and your periods are irregular or absent, raise weight gain and exercise load specifically — this is a recommendation in the guideline, not an afterthought.
6. Keep folic acid and vitamin D going throughout. Whatever else is being discussed, 400 micrograms of folic acid daily is the intervention with the strongest evidence behind it.

When to seek help

NG257 recommends offering both partners assessment and investigation after 1 year of unprotected vaginal intercourse without conception, and referral at first presentation if the woman trying to conceive is 36 or over, or if either partner has a suspected or known clinical cause of infertility. Weight is not a reason to delay meeting those thresholds.

Ask to be seen sooner if your periods are irregular or absent, if you have a PCOS diagnosis, or if you are 36 or over. And if a referral is being deferred pending weight loss, ask for that decision in writing with the criterion named — a written rule can be checked, appealed or planned around, while an informal one cannot.